搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
2 天
The Surprising Diabetes Treatment That May Nix Your Need for Insulin
"These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with ...
ExtremeTech on MSN
4 天
New Diabetes Treatment Eliminates Need for Insulin In Most Patients
The experimental therapy takes just a few weeks and removed insulin from the equation for 86% of trial participants.
Medscape
1 天
Oral Semaglutide May Boost Liver Health in Type 2 Diabetes
Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...
1 天
on MSN
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...
Inverse
2 天
Can a Low-Carb Diet Reverse Type 2 Diabetes? A New Study Suggests It Might
A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 ...
2 天
on MSN
Natural Remedies from Flowers May Help Manage Diabetes
This video transcription highlights the potential of using natural remedies derived from flowers to manage diabetes. It ...
Knowridge
1 天
New drug combo shows promise for managing type 2 diabetes
Type 2 diabetes is a common condition in which the body struggles to use insulin properly, causing blood sugar levels to rise ...
2 天
on MSN
Diabetes could lead to coma or death—Are you at risk?
Dr Rajiv Kovil, Head of Diabetology at Zandra Healthcare and Co-Founder of Rang De Neela Initiative, shared, “Type 1 diabetes ...
Knowridge
2 天
A new drug shows promising results for weight loss and diabetes management
Scientists from Yale and other research institutions have discovered that a drug originally developed to treat type 2 ...
59 分钟
Analyzing heart and kidney outcomes after canagliflozin treatment in older adults
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈